Researchers at the National Institutes of Health have a possible explanation for why iron can sometimes worsen malaria infection. By studying mice and samples from malaria patients, the researchers found that extra iron interferes with ferroportin, a protein that prevents a toxic buildup of iron in red blood cells and helps protect these cells against malaria infection. They also found that a mutant form of ferroportin that occurs in African populations appears to protect against malaria. These basic findings, published in Science, may help researchers and healthcare officials develop strategies to prevent and treat malaria(link is external) infections, which numbered nearly 216 million worldwide in 2016.
“Our study helps solve a long-standing mystery,” said Tracey Rouault, M.D., the study’s senior author and a senior investigator at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). “Iron supplements can sometimes worsen malaria infection and, conversely, iron deficiency can be protective in some cases. Our findings reveal that ferroportin — its function, as well as its regulation by iron levels — helps to explain these observations.”
The study team found that red blood cells use ferroportin to remove excess iron, which malaria parasites consume as a food source. In studies of mice, the team found that the absence of ferroportin in erythroid cells (red blood cells and their precursors) caused iron to accumulate to toxic levels inside red blood cells. This, in turn, stressed the cells and shortened their life span. In addition, the team found that mice lacking ferroportin had more parasites and worse outcomes when infected with malaria, compared to infected mice with intact ferroportin.
When they fed mice a high-iron diet, the researchers also found that a hormone called hepcidin regulates ferroportin in erythroid cells. The hormone, which is more abundant in high-iron environments, lowered ferroportin levels on erythroblasts (precursors to red blood cells) and, subsequently, in red blood cells. Additionally, hepcidin physically bound to ferroportin, preventing iron from being removed from the cells.
Next, the researchers sought to determine whether a ferroportin mutation, called Q248H, found in African populations protects against malaria. This mutation shields ferroportin from hepcidin’s effects. The team analyzed patient samples from two existing malaria studies.
“Our findings suggest that Q248H does protect against malaria, possibly explaining why it occurs in people who live in malaria-endemic regions,” said De-Liang Zhang, Ph.D., the current study’s lead author.
In one study, which enrolled children hospitalized for malaria in Zambia, the team found that nearly 20 percent of the 66 patients had the mutation. Children with the mutation tended to have fewer malarial parasites in their blood and tolerated their fevers for a longer period before coming to the hospital. While the trends were not statistically significant, they raise the possibility that Q248H reduces the iron available in the blood, therefore reducing the malaria parasite’s food source.
In the other study, which enrolled 290 pregnant women in Ghana, the researchers found that nearly 9 percent had the mutation. Women with the mutation were significantly less likely to have pregnancy-associated malaria, in which parasites accumulate in the placenta and can cause adverse pregnancy and birth outcomes.
“Given the importance of iron metabolism overall, we will continue studying the ferroportin mutation and explore its other potential health effects,” added Dr. Zhang.
Funding for the study was provided by NICHD and the National Institute of Allergy and Infectious Diseases.
About the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): NICHD conducts and supports research in the United States and throughout the world on fetal, infant and child development; maternal, child and family health; reproductive biology and population issues; and medical rehabilitation. For more information, visit NICHD’s website.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®
Zhang D.L. et al., Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis and malaria risk. Science DOI: 10.1126/science.aal2022 (2018)
The Southern Maryland Chronicle is a local, small business entrusted to provide factual, unbiased reporting to the Southern Maryland Community. While we look to local businesses for advertising, we hope to keep that cost as low as possible in order to attract even the smallest of local businesses and help them get out to the public. We must also be able to pay employees(part-time and full-time), along with equipment, and website related things. We never want to make the Chronicle a “pay-wall” style news site.
To that end, we are looking to the community to offer donations. Whether it’s a one-time donation or you set up a reoccurring monthly donation. It is all appreciated. All donations at this time will be going to furthering the Chronicle through hiring individuals that have the same goals of providing fair, and unbiased news to the community. For now, donations will be going to a business PayPal account I have set-up for the Southern Maryland Chronicle, KDC Designs. All business transactions currently occur within this PayPal account. If you have any questions regarding this you can email me at firstname.lastname@example.org
Thank you for all of your support and I hope to continue bringing Southern Maryland the best news possible for a very long time. — David M. Higgins II